Lorcainide

HCID 42884CAS 59729-31-6

기본 정보

표준 SMILES
CC(C)N1CCC(N(C(=O)Cc2ccccc2)c2ccc(Cl)cc2)CC1
InChIKey
XHOJAWVAWFHGHL-UHFFFAOYSA-N
분자식
C22H27ClN2O
평균 분자량
370.9 g/mol
단동위원소 질량
370.18119116

개요

Lorcainide is a member of acetamides.

이름 및 식별자

우선 이름
Lorcainide
IUPAC
N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-4-yl)acetamide
영어명
Lorcainide
분자식
C22H27ClN2O
분자량
370.92

이름 및 동의어

LORCAINIDE59729-31-6lorcainidLorcainidaLorcainidumKGJ2T0N7IQRo 13-10424'-Chloro-N-(1-isopropyl-4-piperidyl)-2-phenylacetanilideN-(4-Chlorophenyl)-N-(1-(1-methylethyl)-4-piperidinyl)benzeneacetamideDTXSID2023226RO-13-1042Benzeneacetamide, N-(4-chlorophenyl)-N-(1-(1-methylethyl)-4-piperidinyl)-
이름 더 보기
R-15889LorcamideLopantrolRo-13。1042Lorivox:RemivoxLorcainide USP/EP/BPN-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-4-yl)acetamideN-(4-Chlorophenyl)-N-[1-(1-methylethyl)piperidin-4-yl]benzeneacetamideN-(4-Chlorophenyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzeneacetamide
N-(4-chlorophenyl)-2-phenyl-N-[1-(propan-2-yl)piperidin-4-yl]acetamideBenzeneacetamide, N-(4-chlorophenyl)-N-[1-(1-methylethyl)-4-piperidinyl]-N-(4-chlorophenyl)-2-phenyl-N-(1-(propan-2-yl)piperidin-4-yl)acetamideRefChem:154097R15889DTXCID703226C01BC07N-(4-chlorophenyl)-N-(1-(1-methylethyl)-4-piperidinyl)benzeneacetamide.HCl

데이터베이스 식별자

CAS
59729-31-6
PubChem CID
42884
DTXSID
DTXSID2023226
ChEMBL
CHEMBL87543
ChEBI
CHEBI:135568
UNII
KGJ2T0N7IQ
Nikkaji
J18.310E

물성

구조 계산 물성

XLogP
4.6
극성 표면적
23.6 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
5
무거운 원자 수
26

실험 및 물리화학적 성질

LogP · 2건

4.85

4.85

Melting Point263 °C
Physical DescriptionSolid

물리화학적 성질

녹는점
263 °C · 263 °C
끓는 점
503 · 503.0±50.0 °C(Predicted)
밀도
1.161 · 1.161±0.06 g/cm3(Predicted)
산도 계수 (pKa)
9.48 · 9.48±0.20(Predicted)

안전 및 규제

안전 데이터

독성
LD50 in male mice, male and female rats (mg/kg): 18.8, 19.3, 18.6 i.v.; 483, 395, 435 orally (Barton, Marsboom)

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 1건

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Cellular LocationsMembrane

응용 분야

용도Cardiac depressant (anti-arrhythmic).

공급사5 곳

Sinoway Industrial co., ltd.+86-0592-5800732 +86-13806035118 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
武汉德拜技术有限公司18086626237 18086626237 · [email protected]
陕西缔都医药化工有限公司+86-29-81139210 +86-17392587031 · [email protected]

관련 반응

0건

현재 필터 조건에 해당하는 반응 기록이 없습니다.

연결된 노트

불러오는 중…